An update on cladribine for relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An update on cladribine for relapsing-remitting multiple sclerosis

Published:2017-09-11 Issue:15 Volume:18 Page:1627-1635
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Holmøy Trygve¹²,Torkildsen Øivind³⁴⁵,Myhr Kjell-Morten³⁴⁵

Affiliation:

1. Department of Neurology, Akershus University Hospital, Lørenskog, Norway

2. Institute of Clinical Medicine, Univeristy of Oslo, Oslo, Norway

3. Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway

4. Department of Clinical Medicine, University of Bergen, Bergen, Norway

5. Department of Neurology, Haukeland University Hospital, Bergen, Norway

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1372747

Reference81 articles.

1. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

2. Cost of Illness of Multiple Sclerosis - A Systematic Review

3. Affordability of medicines in the European Union

4. Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecules from Bacopa monneiri as potent inhibitors against Neurodegenerative disorders;2022-04-01

2. DFT study of Ni-doped graphene nanosheet as a drug carrier for multiple sclerosis drugs;Computational and Theoretical Chemistry;2021-02

3. In-silico studies of Neurocognitive and Neuropharmacological effect of Bacopa monnieri (L.);2021-01-21

4. Cladribina para el tratamiento de la esclerosis múltiple remitente recurrente: nueva alternativa para Latinoamérica;Latin american journal of clinical sciences and medical technology;2020-06-25

5. Cladribina para el tratamiento de la esclerosis múltiple remitente recurrente: nueva alternativa para Latinoamérica;Latin american journal of clinical sciences and medical technology;2020-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3